Kyle T. Colvett
Expertise in
11
conditions

Dr. Kyle T. Colvett

Radiation Oncology
400 N State Of Franklin Rd, 
Johnson City, TN 
Accepting New Patients
Referral may be required
Before you request
Expertise in
11
conditions
400 N State Of Franklin Rd, 
Johnson City, TN 

Overview

Kyle Colvett is a Radiation Oncologist practicing medicine in Johnson City, Tennessee.

Dr. Colvett is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Laryngeal Cancer, Pleuropulmonary Blastoma, and Lung Cancer.

Dr. Colvett is board certified in American Board Of Radiology. He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 3 clinical trials. Dr. Colvett is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in TN
  in  

Board Certifications

American Board Of Radiology

Fellowships

 

Hospital Affiliations

 
Wellmont Bristol Regional Medical Center
Indian Path Community Hospital
Wellmont Holston Valley Medical Center
Johnson City Medical Center
Franklin Woods Community Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Appalachian Radiation Oncology Associates PC
400 N State Of Franklin Rd, Johnson City, TN 37604

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2a Randomized, Parallel Group, Open Label, Multicenter Study to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Locally Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
A Phase 2a Randomized, Parallel Group, Open Label, Multicenter Study to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Locally Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
Enrollment Status: Completed
Publish Date: November 04, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 2
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Radiation, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

2 Total Publications

PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy.
PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy.
Journal: International journal of radiation oncology, biology, physics
Published: August 03, 2022
Similar Doctors
Expertise in
21
conditions
Dr. Matthew C. Hull
Radiation Oncology
Expertise in
21
conditions
Dr. Matthew C. Hull
Radiation Oncology
Referral may be required

Mountain Radiation Oncology

21 Hospital Dr, 
Asheville, NC 
 (51.2 miles away)
828-213-0100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Matthew Hull is a Radiation Oncologist practicing medicine in Asheville, North Carolina. Dr. Hull is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Hull is currently accepting new patients.

Expertise in
11
conditions
Dr. Jonas V. Sidrys
Radiation Oncology
Expertise in
11
conditions
Dr. Jonas V. Sidrys
Radiation Oncology
Referral may be required
Before you request

Appalachian Radiation Oncology Associates PC

400 N State Of Franklin Rd, 
Johnson City, TN 
 (0.1 miles away)
423-431-6000
Languages Spoken:
English, Lingala
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonas Sidrys is a Radiation Oncologist practicing medicine in Johnson City, Tennessee. Dr. Sidrys is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Familial Prostate Cancer, Prostate Cancer, and Breast Cancer. Dr. Sidrys is board certified in American Board Of Radiology. Dr. Sidrys is currently accepting new patients.

Expertise in
17
conditions
Dr. Matthew M. Gestaut
Radiation Oncology
Expertise in
17
conditions
Dr. Matthew M. Gestaut
Radiation Oncology
Referral may be required
Before you request

J.D. Nicewonder Family Pediatric Emergency Department

1 Medical Park Blvd, 
Bristol, TN 
 (20.5 miles away)
423-844-1121
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Matthew Gestaut is a Radiation Oncologist practicing medicine in Bristol, Tennessee. Dr. Gestaut is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Posterior Fossa Tumor. Dr. Gestaut is board certified in American Board Of Radiology. Dr. Gestaut is currently accepting new patients.

Frequently Asked Questions about Dr. Kyle T. Colvett

How do I make an appointment with Dr. Kyle T. Colvett?

You can book an appointment with Dr. Kyle T. Colvett by calling their office at 423-431-6000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kyle T. Colvett a top-rated expert for Oral Squamous Cell Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kyle T. Colvett is classified as an Distinguished expert for Oral Squamous Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kyle T. Colvett specialize in?

While Dr. Kyle T. Colvett is a Radiation Oncology, they have specific expertise in Oral Squamous Cell Carcinoma, Laryngeal Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Kyle T. Colvett participate in research or clinical trials?

Yes. Dr. Kyle T. Colvett has published 2 articles and abstracts on conditions like Oral Squamous Cell Carcinoma. You can view a list of Dr. Kyle T. Colvett's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kyle T. Colvett accept my insurance?

Dr. Kyle T. Colvett accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 423-431-6000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Colvett's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 65 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile